Literature DB >> 24939360

Evidence that glycine induces lipid peroxidation and decreases glutathione concentrations in rat cerebellum.

Alana Pimentel Moura1, Mateus Grings, Gustavo Flora Marcowich, Anna Paula Bumbel, Belisa Parmeggiani, Leonardo de Moura Alvorcem, Moacir Wajner, Guilhian Leipnitz.   

Abstract

Patients with non-ketotic hyperglycinemia (NKH) present severe neurological symptoms and brain abnormalities involving cerebellum. Although the pathomechanisms underlying the cerebellum damage have not been studied, high tissue levels of glycine (GLY), the biochemical hallmark of this disorder have been suggested to contribute to the neuropathology of this disease. We investigated the in vitro effects of GLY on important parameters of oxidative stress and energy metabolism in cerebellum of 30-day-old rats. Our results show that GLY increased 2',7'-dichlorofluorescin oxidation, suggesting that reactive species production are augmented by GLY in the cerebellum. However, hydrogen peroxide generation was not altered by GLY. GLY also increased thiobarbituric acid-reactive substances (TBA-RS) levels and reduced the glutathione (GSH) content, indicating that this amino acid provokes lipid oxidative damage and compromises the non-enzymatic antioxidant defenses, respectively, in cerebellum. The antioxidants melatonin and trolox (the hydrosoluble analog of vitamin E) prevented the GLY-induced increase of TBA-RS and decrease of GSH in cerebellum, indicating the involvement of hydroxyl and peroxyl radicals in these effects. The NMDA receptor antagonist MK-801 also attenuated GLY-induced decrease of GSH, suggesting that this effect is mediated through NMDA receptor. In contrast, GLY did not alter the protein carbonyl formation and total and protein-bound sulfhydryl group content, as well as catalase and superoxide dismutase activities. Furthermore, GLY did not alter the activities of the respiratory chain complexes and creatine kinase. Our present data indicate that oxidative stress elicited by GLY in vitro may be a potential pathomechanism involved in the cerebellar dysfunction observed in NKH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24939360     DOI: 10.1007/s11010-014-2118-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  51 in total

1.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera.

Authors:  B P HUGHES
Journal:  Clin Chim Acta       Date:  1962-09       Impact factor: 3.786

2.  Prediction of long-term outcome in glycine encephalopathy: a clinical survey.

Authors:  Julia B Hennermann; Jeanne-Marie Berger; Ulrike Grieben; Gunter Scharer; Johan L K Van Hove
Journal:  J Inherit Metab Dis       Date:  2011-10-15       Impact factor: 4.982

3.  Mitochondrial membrane protein thiol reactivity with N-ethylmaleimide or mersalyl is modified by Ca2+: correlation with mitochondrial permeability transition.

Authors:  A J Kowaltowski; A E Vercesi; R F Castilho
Journal:  Biochim Biophys Acta       Date:  1997-02-15

4.  Regulation of cytochrome c oxidase and FoF1-ATPase subunits expression in rat brain during aging.

Authors:  V G Nicoletti; E A Tendi; A Console; A Privitera; R F Villa; N Ragusa; A M Giuffrida-Stella
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

5.  Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations.

Authors:  Z Matuszak; K Reszka; C F Chignell
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

6.  Oxidative damage to proteins: spectrophotometric method for carbonyl assay.

Authors:  A Z Reznick; L Packer
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

7.  Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.

Authors:  A H Schapira; V M Mann; J M Cooper; D Dexter; S E Daniel; P Jenner; J B Clark; C D Marsden
Journal:  J Neurochem       Date:  1990-12       Impact factor: 5.372

8.  Proton magnetic resonance spectroscopy of the brain of a neonate with nonketotic hyperglycinemia: in vivo-in vitro (ex vivo) correlation.

Authors:  T A G M Huisman; T Thiel; B Steinmann; G Zeilinger; E Martin
Journal:  Eur Radiol       Date:  2001-08-28       Impact factor: 5.315

9.  Glycine provokes lipid oxidative damage and reduces the antioxidant defenses in brain cortex of young rats.

Authors:  Guilhian Leipnitz; Alexandre F Solano; Bianca Seminotti; Alexandre U Amaral; Carolina G Fernandes; Ana Paula Beskow; Carlos S Dutra Filho; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2008-10-02       Impact factor: 5.046

10.  Noninvasive detection of increased glycine content by proton MR spectroscopy in the brains of two infants with nonketotic hyperglycinemia.

Authors:  W Heindel; H Kugel; B Roth
Journal:  AJNR Am J Neuroradiol       Date:  1993 May-Jun       Impact factor: 3.825

View more
  4 in total

1.  Sex-related differences in plasma amino acids of patients with ST-elevation myocardial infarction and glycine as risk marker of acute heart failure with preserved ejection fraction.

Authors:  Oleg B Iaremenko; Nataliia Kh Iordanova; Petro F Dudka; Tamara M Kuchmerovska
Journal:  Amino Acids       Date:  2022-07-02       Impact factor: 3.789

2.  Intracerebral Glycine Administration Impairs Energy and Redox Homeostasis and Induces Glial Reactivity in Cerebral Cortex of Newborn Rats.

Authors:  Alana Pimentel Moura; Belisa Parmeggiani; Mateus Grings; Leonardo de Moura Alvorcem; Rafael Mello Boldrini; Anna Paula Bumbel; Marcela Moreira Motta; Bianca Seminotti; Moacir Wajner; Guilhian Leipnitz
Journal:  Mol Neurobiol       Date:  2015-10-26       Impact factor: 5.590

3.  Biochemical, Metabolic, and Behavioral Characteristics of Immature Chronic Hyperphenylalanemic Rats.

Authors:  Gerald A Dienel; Nancy F Cruz
Journal:  Neurochem Res       Date:  2015-07-30       Impact factor: 3.996

4.  Metabolomics in Glaucoma: A Systematic Review.

Authors:  Ying Wang; Xiao-Wen Hou; Gang Liang; Chen-Wei Pan
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-05-03       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.